LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects.

Respir Med · 2011 · PMC7127613 · PMID 21251805

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

HRV-16 replication was lower in subjects receiving LTB4, but this difference failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.